Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-020512
Filing Date
2020-03-20
Accepted
2020-03-20 17:55:41
Documents
1
Period of Report
2020-03-19

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4343
  Complete submission text file 0001209191-20-020512.txt   5790
Mailing Address C/O OUTLOOK THERAPEUTICS, INC. 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address
KENYON LAWRENCE A (Reporting) CIK: 0001230484 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 20733095

Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Outlook Therapeutics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)